Patrik Fagerholm
Director of Finance/CFO at NEXTCELL PHARMA AB
Network origin in Patrik Fagerholm first degree
Entity | Entity type | Industry | |
---|---|---|---|
Public Company | Pharmaceuticals: Major | 9 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Patrik Fagerholm via their personal network
Company | Sector | Related people | Main position |
---|---|---|---|
Karolinska Institutet | College/University | Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
European Society of Gene & Cell Therapy | Director/Board Member | ||
Dilafor AB
Dilafor AB Pharmaceuticals: MajorHealth Technology Dilafor AB develops pharmaceutical products from heparin derivatives with low anticoagulant activity. It investigates document and exploits the pharmacological properties of derivatives in the field of obstetrics. The company was founded by Gunvor Ester Ekman-Ordeberg, Hans-Peter Ekre, Per-Olov Eriksson, Per Giléus, Kjell Gunnarsson, Erik Yngve Holmer, Göran Kvist, Ulf Lindahl, Anders Malmström, Tore Mellstrand, Johan Rasin, and Mats Wahlgren in 2003 and is headquartered in Solna, Sweden. | Pharmaceuticals: Major | Founder | |
European Society for Medical Oncology
European Society for Medical Oncology Medical/Nursing ServicesHealth Services The European Society for Medical Oncology (ESMO) is a leading medical oncology society that provides a professional network for its members and works with national societies across Europe. The non-profit company is based in Lugano, Switzerland. ESMO's position on a wide range of legislative and non-legislative policy files on both EU and levels is available to learn about. Raffaella Casolino is the third ESMO young medical oncologist serving as a cancer expert on the WHO Cancer Control team. ESMO's Young Oncologists Corner is dedicated to providing educational and networking opportunities for medical oncologists under 40. | Medical/Nursing Services | President | |
Palette Life Sciences AB
Palette Life Sciences AB Medical SpecialtiesHealth Technology Palette Life Sciences AB operates as a pharmaceutical company. It specializes in developing products for local pain relief in obstetrics and gynecology. The company was founded by Berith Karlsson Tingåker, Gunvor Ekman-Ordeberg, Arne Folke Brodin and Lars Irestedt in 2009 and is headquartered in Solna, Sweden. | Medical Specialties | Director/Board Member | |
Karolinska University Hospital
Karolinska University Hospital Hospital/Nursing ManagementHealth Services Karolinska University Hospital is a premier health facility and one of Europe's largest teaching hospitals located in Stockholm, Sweden. The Swedish company provides healthcare services for a wide range of disorders, from major public health diseases to rare medical conditions. As a designated provider of highly specialized medical services, they have a primary responsibility for the clinical components of research and education. Together with the world-respected Karolinska Institutet, they lead in medical breakthroughs. The company educates and train tomorrow's medical specialists and healthcare professionals as a major teaching hospital. | Hospital/Nursing Management | Corporate Officer/Principal | |
MIRIS HOLDING AB | Electronic Equipment/Instruments | Chief Executive Officer | |
BioLamina AB
BioLamina AB BiotechnologyHealth Technology BioLamina AB develops, manufactures and markets cell culture reagents intended for culturing of primary cells. Its applications animal stem cells, cancer cells, cardiac applications, clonal applications, endothelial applications, epithelial applications, expansion of human PSC, eye applications, hepatic applications, intestinal applications, kidney cell culture, lung applications, neural applications, pancreatic applications and skeletal muscle applications. The company was founded by Kristian Tryggvason and Karl Tryggvason in 2008 and is headquartered in Sundbyberg, Sweden. | Biotechnology | Sales & Marketing | |
University of Oslo | College/University | Masters Business Admin | |
MONIVENT AB | Medical Specialties | Director/Board Member | |
Roche AB
Roche AB Pharmaceuticals: MajorHealth Technology Part of Roche Holding AG, Roche AB is a biotechnology company founded in 1896. The company is based in Solna, Sweden and creates innovative treatments to help millions of patients worldwide. Roche actively seeks partnerships with healthcare providers, academia, patient associations, organizations, external companies, and startups to identify needs that form the basis for collaborations. Roche is one of the world's largest research-based biotechnology companies, focusing on advancing science to improve people's lives. The Swedish company develops both drugs and diagnostics and has great respect for the multiple perspectives required to create tomorrow's healthcare. | Pharmaceuticals: Major | Corporate Officer/Principal | |
KCIF Fund Management AB | Chief Executive Officer | ||
KANCERA AB | Pharmaceuticals: Major | Director/Board Member | |
KAROLINSKA DEVELOPMENT AB | Financial Conglomerates | Chief Investment Officer | |
NovaSAID AB
NovaSAID AB Pharmaceuticals: MajorHealth Technology NovaSAID AB develops treatments for inflammation and pain in conditions such as rheumatoid arthritis. It discovers selective microsomal prostaglandin E synthase-1 (mPGES-1), and has also demonstrated its effect in animal models for pain and inflammation. The firm's approach is to prevent the pathological formation of prostaglandin E2 (PGE2) selectively, through the development of inhibitors of mPGES-1, the enzyme that is responsible for the formation of PGE2 during inflammation. Its mPGES-1 inhibition offers an approach for inhibiting pathological PGE2 production without adversely affecting other important prostanoids. The company was founded by Per-Johan Göte Jakobsson, Ralf Morgenstern, Bertil Samuelsson and Bengt Ingemar Samuelsson on October 26, 2004 and is headquartered in Solna, Sweden. | Pharmaceuticals: Major | Chairman | |
ProNoxis AB
ProNoxis AB Pharmaceuticals: MajorHealth Technology ProNoxis AB develops small-molecule drugs to treat chronic inflammation. The company was founded in 2009 and is headquartered in Lund, Sweden. | Pharmaceuticals: Major | Director/Board Member | |
KDev Exploratory AB
KDev Exploratory AB Miscellaneous Commercial ServicesCommercial Services KDev Exploratory AB provides drug discovery solutions. It performs discovery research in various therapeutic areas, such as screening in oncology, neuroscience, lead finding, characterization in inflammation and angiogenesis/age-related macular degeneration. The company was founded by David Jern in 2000 and is headquartered in Solna, Sweden. | Miscellaneous Commercial Services | Director/Board Member | |
IMED AB
IMED AB Drugstore ChainsRetail Trade IMED AB is focused on the development and commercialization of fully human monoclonal antibodies for treatment of immune disorders and diseases such as ischemia/reperfusion injury, HIV and cancer. IMED’s unique antibodies modulate the natural process of cell death called apoptosis by selective and specific blocking or induction of central signaling pathways. IMED AB is a privately owned biotechnology company funded by Karolinska Development and LinkMed AB and intends to out-license its products to pharmaceutical companies. | Drugstore Chains | Director/Board Member | |
Karolinska Development AB (Private Equity)
Karolinska Development AB (Private Equity) Investment ManagersFinance Karolinska Development AB (Private Equity) (Karolinska Development) is a Venture Capital firm, a subsidiary of Karolinska Development AB founded in 2003. The firm is headquartered in Solna. | Investment Managers | Private Equity Investor | |
Companion Medical, Inc.
Companion Medical, Inc. Medical SpecialtiesHealth Technology Companion Medical, Inc. develops solutions for diabetes management called InPen. The company was founded by Sean Saint in 2013 and is headquartered in San Diego, CA. | Medical Specialties | Director/Board Member | |
Armea AB | Director/Board Member | ||
Diamyd Diagnostics AB | Director/Board Member | ||
DIAMYD MEDICAL AB | Pharmaceuticals: Major | Founder | |
Synectics Medical AB
Synectics Medical AB Information Technology ServicesTechnology Services Part of Medtronic Plc, Synectics Medical AB is a Swedish company that develops computer support systems for the healthcare industry. The company is based in Stockholm, Sweden. The company was founded by Anders Essen-Möller. Synectics Medical was acquired by Medtronic, Inc., part of Medtronic Plc from January 27, 2015 on March 11, 1996 for $59 million. | Information Technology Services | Founder | |
University of Lund | College/University | Graduate Degree | |
ELLEN AB | Pharmaceuticals: Major | Director of Finance/CFO |
Statistics
International
Sweden | 29 |
United States | 3 |
Belgium | 2 |
Switzerland | 2 |
Norway | 2 |
Sectoral
Health Technology | 18 |
Consumer Services | 4 |
Finance | 4 |
Commercial Services | 3 |
Health Services | 3 |
Operational
Director/Board Member | 22 |
Founder | 8 |
Corporate Officer/Principal | 6 |
Chief Tech/Sci/R&D Officer | 6 |
Chairman | 5 |
Most connected contacts
- Stock Market
- Insiders
- Patrik Fagerholm
- Company connections